Theravance Biopharma, Inc.
US ˙ NasdaqGM ˙ KYG8807B1068

SecurityTBPH / Theravance Biopharma, Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership21,747 shares
Latest Disclosed Value $ 352,954
Citigroup Inc reports 58.03% increase in ownership of TBPH / Theravance Biopharma, Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 21,747 shares of Theravance Biopharma, Inc. (US:TBPH) valued at $352,954 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 13,761 shares of Theravance Biopharma, Inc.. This represents a change in shares of 58.03% during the quarter. The current value of the position is $346,212 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 21,747 7,986 58.03 353 36.96 0.0001
2026-02-13 2025-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 13,761 5,678 70.25 257 117.80 0.0001
2025-11-10 2025-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 8,083 -9,529 -54.11 118 -39.18 0.0001
2025-08-11 2025-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 17,612 -12,150 -40.82 194 -26.79 0.0001
2025-05-12 2025-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 29,762 -2,684 -8.27 266 -13.11 0.0001
2025-02-12 2024-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 32,446 3,357 11.54 305 30.34 0.0002
2024-11-12 2024-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 29,089 14,201 95.39 234 85.71 0.0001
2024-08-12 2024-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 14,888 -10,719 -41.86 126 -44.98 0.0001
2024-05-10 2024-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 25,607 10,867 73.72 230 38.79 0.0002
2024-02-09 2023-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 14,740 9,161 164.21 166 243.75 0.0001
2023-12-06 2023-09-30 13F/A-1 THERAVANCE BIOPHARMA COM G8807B106 5,579 -19,054 -77.35 48 -81.10 0.0000
2023-11-09 2023-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 5,579 -19,054 48 0.0000
2023-08-10 2023-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 24,633 17,585 249.50 255 234.21 0.0002
2023-05-11 2023-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 7,048 -971 -12.11 76 -14.61 0.0001
2023-02-09 2022-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 8,019 -3,647 -31.26 90 -24.58 0.0001
2022-11-10 2022-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 11,666 -6,234 -34.83 118 -27.16 0.0001
2022-08-10 2022-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 17,900 -2,692 -13.07 162 -17.77 0.0001
2022-05-12 2022-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 20,592 119 0.58 197 -12.83 0.0001
2022-02-10 2021-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 20,473 -16,117 -44.05 226 -16.61 0.0001
2021-11-10 2021-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 36,590 26,685 269.41 271 88.19 0.0002
2021-08-10 2021-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 9,905 3,626 57.75 144 12.50 0.0001
2021-05-13 2021-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 6,279 -14,589 -69.91 128 -65.50 0.0001
2021-02-11 2020-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 20,868 11,195 115.73 371 159.44 0.0002
2020-11-12 2020-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 9,673 -29,302 -75.18 143 -82.54 0.0001
2020-08-12 2020-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 38,975 20,300 108.70 819 89.58 0.0006
2020-05-12 2020-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 18,675 4,951 36.08 432 21.35 0.0004
2020-02-12 2019-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 13,724 6,595 92.51 356 157.97 0.0003
2019-11-08 2019-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 7,129 -7,051 -49.72 138 -40.26 0.0001
2019-08-12 2019-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 14,180 1,576 12.50 231 -18.95 0.0002
2019-05-13 2019-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 12,604 6,123 94.48 285 71.69 0.0003
2019-02-12 2018-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 6,481 4,673 258.46 166 181.36 0.0002
2018-11-13 2018-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 1,808 1,432 380.85 59 555.56 0.0001
2018-08-10 2018-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 376 158 72.48 9 80.00 0.0000
2018-05-11 2018-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 218 -140 -39.11 5 -50.00 0.0000
2018-02-12 2017-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 358 -9,334 -96.31 10 -96.99 0.0000
2017-11-13 2017-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 9,692 9,502 5,001.05 332 4,050.00 0.0003
2017-08-11 2017-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 190 -65,301 -99.71 8 -99.67 0.0000
2017-05-12 2017-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 65,491 46,906 252.39 2,411 306.58 0.0021
2017-02-10 2016-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 18,585 12,692 215.37 593 178.40 0.0005
2016-11-10 2016-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 5,893 -982 -14.28 213 36.54 0.0002
2016-08-12 2016-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 6,875 -13,567 -66.37 156 -59.37 0.0002
2016-05-13 2016-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 20,442 9,581 88.21 384 115.73 0.0004
2016-02-12 2015-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 10,861 10,857 271,425.00 178 0.0002
2015-11-13 2015-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 4 -5,401 -99.93 0 -100.00
2015-08-13 2015-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 5,405 -1,462 -21.29 70 -41.67 0.0001
2015-05-14 2015-03-31 13F THERAVANCE BIOPHARMA COM G8807B106 6,867 -6,933 -50.24 120 -41.75 0.0001
2015-02-17 2014-12-31 13F THERAVANCE BIOPHARMA COM G8807B106 13,800 11,975 656.16 206 390.48 0.0002
2014-11-14 2014-09-30 13F THERAVANCE BIOPHARMA COM G8807B106 1,825 255 16.24 42 -16.00 0.0000
2014-08-14 2014-06-30 13F THERAVANCE BIOPHARMA COM G8807B106 1,570 1,570 50 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.